跳至主要内容
临床试验/NCT05707767
NCT05707767招募中不适用

A Prospective Study of Surgical Treatment Strategies for Chordoma

Xuanwu Hospital, Beijing2 个研究点 分布在 1 个国家目标入组 100 人开始时间: 2023年2月1日最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
入组人数
100
试验地点
2
主要终点
Excision Extension

研究概览

简要总结

Chordoma is a rare but locally invasive cancer that arises from the embryonic notochord. Total resection is challenging in mobile spine because of the complex anatomy and bone invasion.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 70 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Between the ages of 18 and 70 ys,
  • With a diagnosis of chordoma confirmed by pathology,
  • Undergone surgical treatment in our hospital,
  • Available for clinical follow-up and agree to long-term clinical follow-up and sign informed consent.

排除标准

  • Suffer from other tumors,
  • Suffer from cardiovascular disease, cerebrovascular disease, or immune system disease.

结局指标

主要结局

Excision Extension

时间窗: 1 week after surgery.

Clinical and radiographic assessments of excision extension of tumor.

次要结局

  • ORR (Objective Response Rate)(2 years)
  • DFS (Disease Free Survival)(2 years)
  • PFS (Progression-Free Survival)(2 years)
  • OS (Overall Survival)(2 years)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验